Inpatient and Residential
Withdrawal and Stabilization
Outpatient Withdrawal Rates
Effective January 1, 2021, the reimbursement methodology for Part 816.8 programs - Medically Supervised Outpatient Withdrawal and Stabilization (MSOW) from a provider-specific fee to Ambulatory Patient Groups (APGs)
Residential Services for Youth
Addiction Treatment Centers
Guidance on billing Sublocade intramuscular injection and oral buprenorphine in ambulatory settings), as well as billing for Vivitrol for outpatient programs.
Please note that changes to Chapters 69 and 71 of the Insurance Laws of 2016 prohibit prior Insurance authorization for medications for treatment of substance use disorder.
Contact Practice Innovation & Care Management Unit
If you have any questions, contact the Division of Practice Innovation and Care Management (PICM).